XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cost of goods sold $ (671) $ (640)
Gross profit 2,884 1,006
Operating expenses:    
Research and development expenses 13,778 11,201
Selling, general and administrative expenses 13,637 11,108
Total operating expenses 27,415 22,309
Operating loss (24,531) (21,303)
Change in fair value of the warrant liability, net   (2,832)
Interest expense, net (1,186) (175)
Other income 68 154
Net loss (25,649) (24,156)
Deemed dividend for triggering of warrant down round feature   (55)
Net loss attributable to common stockholders (25,649) (24,211)
Net loss (25,649) (24,156)
Other comprehensive income (loss):    
Foreign currency translation adjustments 122 (132)
Total other comprehensive loss $ (25,527) $ (24,288)
Common share data:    
Basic and diluted loss per common share $ (3.59) $ (8.35)
Weighted average number of basic and diluted shares outstanding 7,145,754 2,897,827
Product Revenue [Member]    
Revenue $ 1,300 $ 1,156
Other Revenue [Member]    
Revenue $ 2,255 $ 490